Baseline Epidemiology of Streptococcus pneumoniae Serotypes in Canada Prior to the Introduction of the 13-Valent Pneumococcal Vaccine
- 1 April 2012
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 18 (2) , 176-182
Abstract
Changes in the epidemiology of Streptococcus pneumoniae were reported worldwide after the introduction of the 7-valent pneumococcal vaccine, particularly an increase in multi-drug resistant (MDR) 19A strains. Subsequently, a 13-valent pneumococcal vaccine (PCV-13) has been introduced. This study assessed the incidence of S. pneumoniae serotypes in all age groups prior to the introduction of PCV-13 in Canada (2007–2009). Eight hundred S. pneumoniae isolates from respiratory specimens and blood cultures were collected as part of a Canadian surveillance study (CANWARD) from patients in 15 tertiary-care centers. Serotyping was performed by the Quellung method and antimicrobial susceptibility testing was performed by broth microdilution in accordance with the Clinical and Laboratory Standards Institute guidelines. The most common serotypes were 19A (8.6%), 3 (7.3%), 22F (6.0%), 4 (4.6%), 5 (4.4%), and 11A (4.4%); and the first serotype 6D isolate in Canada was identified. Serotypes 5, 7F, and 19A were significantly ( p p p S. pneumoniae serotypes in Canada are included in PCV-13. Notably, 87.5% of MDR- S. pneumoniae were covered by PCV-13. Accordingly, PCV-13 will provide coverage against a significant proportion of circulating S. pneumoniae strains in Canada, including the critical antimicrobial-resistant strains.Keywords
This publication has 8 references indexed in Scilit:
- Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccineEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 studyDiagnostic Microbiology and Infectious Disease, 2011
- Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?BMC Pediatrics, 2010
- Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterizationMicrobiology, 2010
- The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007Vaccine, 2010
- Increased Antimicrobial Resistance Among Nonvaccine Serotypes of Streptococcus pneumoniae in the Pediatric Population After the Introduction of 7-Valent Pneumococcal Vaccine in the United StatesThe Pediatric Infectious Disease Journal, 2007
- Epidemiological differences among pneumococcal serotypesThe Lancet Infectious Diseases, 2005
- Epidemiological differences among pneumococcal serotypesThe Lancet Infectious Diseases, 2005